Cargando…

Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential

Progenitor-like cancer cells that can survive in reversible quiescence when faced with various challenges in the body are often behind disease progression. A lack of glutamine in culture medium, which eliminates >99.9% of proliferating SUM149 triple-negative breast cancer cells, selects such adap...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Balraj, Sarli, Vanessa N., Kinne, Hannah E., Shamsnia, Anna, Lucci, Anthony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2019
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557209/ https://www.ncbi.nlm.nih.gov/pubmed/31217902 http://dx.doi.org/10.18632/oncotarget.26978

Ejemplares similares

Correction: Evaluation of 6-mercaptopurine in a cell culture model of adaptable triple-negative breast cancer with metastatic potential
por: Singh, Balraj, et al.
Publicado: (2022)

Inhibition of resistant triple-negative breast cancer cells with low-dose 6-mercaptopurine and 5-azacitidine
por: Singh, Balraj, et al.
Publicado: (2021)

Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer
por: Singh, Balraj, et al.
Publicado: (2023)

Highly Adaptable Triple-Negative Breast Cancer Cells as a Functional Model for Testing Anticancer Agents
por: Singh, Balraj, et al.
Publicado: (2014)

A usable model of “decathlon winner” cancer cells in triple-negative breast cancer: survival of resistant cancer cells in quiescence
por: Singh, Balraj, et al.
Publicado: (2018)

Important Role of FTO in the Survival of Rare Panresistant Triple-Negative Inflammatory Breast Cancer Cells Facing a Severe Metabolic Challenge
por: Singh, Balraj, et al.
Publicado: (2016)

Sensitization of Resistant Breast Cancer Cells with a Jumonji Family Histone Demethylase Inhibitor
por: Singh, Balraj, et al.
Publicado: (2022)

Applications of Circulating Tumor Cells and Circulating Tumor DNA in Precision Oncology for Breast Cancers
por: Addanki, Sridevi, et al.
Publicado: (2022)

The effects of 6-mercaptopurine nucleotide derivatives on the growth and survival of 6-mercaptopurine-sensitive and -resistant cell culture lines.
por: Johnston, H. P., et al.
Publicado: (1985)

Circulating tumor cells in non-metastatic triple-negative breast cancer
por: Karhade, Mandar, et al.
Publicado: (2014)

Selection of Metastatic Breast Cancer Cells Based on Adaptability of Their Metabolic State
por: Singh, Balraj, et al.
Publicado: (2012)

ENHANCEMENT OF ANTIBODY SYNTHESIS BY 6-MERCAPTOPURINE
por: Chanmougan, Devendrathan, et al.
Publicado: (1966)

SUPPRESSION OF ALLERGIC UVEITIS BY 6-MERCAPTOPURINE
por: Wirostko, E., et al.
Publicado: (1962)

ANTAGONISTIC EFFECTS OF 6-MERCAPTOPURINE AND COENZYME A ON MITOCHONDRIA AND MITOSIS IN TISSUE CULTURE
por: Biesele, John J.
Publicado: (1955)

STUDIES ON THE ANTI-INFLAMMATORY ACTION OF 6-MERCAPTOPURINE
por: Hurd, Eric R., et al.
Publicado: (1968)

EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS: THE EFFECT OF 6-MERCAPTOPURINE
por: Hoyer, Leon W., et al.
Publicado: (1962)

Crystal structures of five 6-mercaptopurine derivatives
por: Gomes, Lígia R., et al.
Publicado: (2016)

EFFECT OF 6-MERCAPTOPURINE (6-MP) ON DIFFERENT CLASSES OF ANTIBODY
por: Borel, Yves, et al.
Publicado: (1965)

THE EFFECT OF 6-MERCAPTOPURINE ON DELAYED HYPERSENSITIVITY IN GUINEA PIGS
por: Hoyer, John R., et al.
Publicado: (1962)

6-mercaptopurine promotes energetic failure in proliferating T cells
por: Fernández-Ramos, Ana A., et al.
Publicado: (2017)

Toxicity evaluation of 6-mercaptopurine-Chitosan nanoparticles in rats
por: Govindappa, Prem Kumar, et al.
Publicado: (2020)

On the Action of Methotrexate and 6-Mercaptopurine on M. avium Subspecies paratuberculosis
por: Greenstein, Robert J., et al.
Publicado: (2007)

Childhood lymphoblastic leukaemia: sex difference in 6-mercaptopurine utilization.
por: Lilleyman, J. S., et al.
Publicado: (1984)

MECHANISMS IN THE SUPPRESSION OF DELAYED HYPERSENSITIVITY IN THE GUINEA PIG BY 6-MERCAPTOPURINE
por: Phillips, S. Michael, et al.
Publicado: (1973)

Adherence to 6-Mercaptopurine in children and adolescents with Acute Lymphoblastic Leukemia
por: Alsous, Mervat, et al.
Publicado: (2017)

Practical consensus recommendations on management of triple-negative metastatic breast cancer
por: Rangarao, R., et al.
Publicado: (2018)

Limited Impact of 6-Mercaptopurine on Inflammation-Induced Chemokines Expression Profile in Primary Cultures of Enteric Nervous System
por: Kneusels, Jan, et al.
Publicado: (2021)

Pilot Study of Circulating Tumor Cells in Early-Stage and Metastatic Uveal Melanoma
por: Anand, Kartik, et al.
Publicado: (2019)

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review
por: Gordon, Morris, et al.
Publicado: (2020)

THE EFFECT OF 6-MERCAPTOPURINE AND AMINOPTERIN ON EXPERIMENTAL IMMUNE THYROIDITIS IN GUINEA PIGS
por: Spiegelberg, Hans L., et al.
Publicado: (1963)

The Investigation of the Binding of 6-Mercaptopurine to Site I on Human Serum Albumin
por: Sochacka, Jolanta, et al.
Publicado: (2012)

Effects of 6-mercaptopurine in pressure overload induced right heart failure
por: Axelsen, Julie Birkmose, et al.
Publicado: (2019)

MON-065 Prevention of 6-Mercaptopurine-Induced Hypoglycemia by Levocarnitine Replacement
por: Torchinsky, Michael Yuri, et al.
Publicado: (2020)

Therapeutic Strategies for Metastatic Triple-Negative Breast Cancers: From Negative to Positive
por: Nandini, Dey, et al.
Publicado: (2021)

Metastatic and triple-negative breast cancer: challenges and treatment options
por: Al-Mahmood, Sumayah, et al.
Publicado: (2018)

Patterns of Mutation Enrichment in Metastatic Triple-Negative Breast Cancer
por: Saravia, César H, et al.
Publicado: (2019)

How I treat metastatic triple-negative breast cancer
por: Caparica, Rafael, et al.
Publicado: (2019)

Overview of recent advances in metastatic triple negative breast cancer
por: O'Reilly, David, et al.
Publicado: (2021)

Emerging Therapeutic Drugs in Metastatic Triple-Negative Breast Cancer
por: Cipriano, Élia, et al.
Publicado: (2021)

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer
por: Heeke, Arielle L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ancqfelt8m8gcl1viele61s3md